Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab plus peripheral laser for central retinal vein occlusion
DRKS00000711Phase 2Completed
- Sponsor
- Leipzig University Eye Hospital
- Start
- Feb 2011
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of ranibizumab in central retinal vein occlusion (CRVO) (2 arms), sponsored by Leipzig University Eye Hospital. Started Feb 2011; status: completed.
02
Drugs
ranibizumab
03
Conditions
central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on DRKS00000711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000711.